Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Trev
    Junior Member
    • Dec 2011
    • 1

    #1

    PacBio performance and efficiency in the field

    I have been searching for some down to earth information regarding how the PacBio RS is actually performing that doesn't come from PacBio marketing in terms of both the wet bench side as well as the data quality coming off the system. Is there a honest review of the system out there yet? The system has been out there for awhile now.

    For instance, how is the system performing? I was at a seminar where a sales rep publicly indicated they were having variability problems.

    How many SMRT cells are actually required to not only produce whole-genome sequence data for say an E. coli BUT to produce enough and good enough sequence that can be assembled? The reason I ask is that it looks like from the PacBio publication on the O104 outbreak that it took >50 SMRT cells (cells for both closed circular and long subreads) to assemble the single outbreak isolate. Does it really take this many to get an assembly with PacBio data? Why collect so many if it doesn't?

    What is the final cost of getting assembly quality whole-genome sequencing data off of the PacBio given the number of SMRT cells that need to be run?

    Is the best use of the PacBio RS for whole-genome sequencing in combination with other sequencing data of higher quality and throughput like an Illumina system?

    Is anyone using the PacBio RS for whole-genome sequencing of genomes larger than microbes?

    Is there any public review on the web that lists this information that anyone can link to or comment on? It seems like it is slim pickings out there for actual information.
  • wweise
    Junior Member
    • Jul 2011
    • 1

    #2
    PacBio information from customers

    Full disclosure, I am from the marketing department at Pacific Biosciences but didn't want your question to go unanswered. We have just launched several application-focused pages on our website with customer results, including: webinars, technical posters, peer-reviewed publications, etc. Please visit: www.pacb.com/apps. I hope this helps answer some of your questions....

    Comment

    • petang
      Member
      • Nov 2008
      • 13

      #3
      I am using PB to do de novo genome sequencing of an ~170MB genome.
      The followings are the results form 4 SMRT cells:
      % Adapter Dimer (0-10bp) 3.96
      % Short Insert (11-100bp) 0.51
      Pre-Filter # of Bases 985171659
      Post-Filter # of Bases 537023600
      Pre-Filter # of Reads 601168
      Post-Filter # of Reads 132250
      Pre-Filter Mean Readlength 819
      Post-Filter Mean Readlength 3393
      Pre-Filter Mean Read Quality 0.191
      Post-Filter Mean Read Quality 0.842

      Therefore, around 22% of the reads are QUALITY reads.
      The mean read length of 3Kb is good enough though.

      I will to assemble the datasets and update the result later.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 10-22-2026, 11:13 AM
      0 responses
      29 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 10:48 AM
      0 responses
      21 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      38 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      44 views
      0 reactions
      Last Post SEQadmin2  
      Working...